Skip to main content

Interim Associate Provost and Dean of RSP/Director of BBRI, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University


As a scientist, Deepak Kumar brings expertise in cancer cell and molecular biology, specifically characterizing miRNAs as therapeutic targets and biomarkers for diagnosis, prognosis and stratification. His lab currently focuses on

  1. characterizing molecular targets in prostate, breast, and colon cancer;
  2. microRNAs as biomarkers and therapeutic targets in prostate and breast cancer;
  3. characterizing molecular targets and signaling pathways modulated by micronutrients; and most importantly,
  4. enhancing minority participation in cancer research through education and training in cancer research at all levels.

As director of BBRI, Dr. Kumar serves as the scientific leader of NCCU’s JLC-BBRI research facilities in Durham and Kannapolis, NC (North Carolina Research Campus-NCRC). He is a cancer researcher and has been funded continuously by NIH since his first faculty appointment 15 years ago, most recently via R01 funding to study social epigenomics in prostate cancer and a U01 grant to study epigenetics of prostate cancer disparities. Throughout his career, he has obtained extramural funding in excess of $33 million in grant funds.

Areas of Expertise

  • Cancer cell and molecular biology